Nuclear Dividends: Seriously?

I’ve got some Cameco (CCJ +3.19%), fine. It’s uranium. They dig it up. They refine it. It’s…logical. They’re the second largest, behind Kazakhstan, which, let’s be honest, nobody really thinks about. 17% of the world’s uranium. Okay. Good for them. They’re making money – 15.18% margin. Up 124% in a year. Which is…fine. But I didn’t buy it for a dividend. That’s the problem. You’re looking at this thinking “passive income”? From Cameco? It’s a pittance. $0.17 a share? Seriously? It’s insulting. They raised it twice. By a little. It’s like they’re doing you a favor. I bought it because, well, it might go up. That’s it. If you’re looking for actual income, you’re looking in the wrong place.

AMD: A Discount, So It Goes.

They make chips, these AMD folks. Not the kind you eat. The kind that make computers think. And now, they’re trying to make computers seem to think, with this artificial intelligence business. A lot of hype, naturally. But also, a lot of potential. They say a trillion-dollar market. Which is, frankly, a ridiculous number. But numbers are just numbers, aren’t they?

Super Micro & the AI Fickleness

The S&P 500 (^GSPC 0.06%) experienced a negligible decline, settling at 6,939. The Nasdaq Composite (^IXIC 0.06%) fared little better, drifting down to 23,515. Among the company’s peers, Dell Technologies (DELL +0.73%) managed a modest gain, while Hewlett Packard Enterprise (HPE 2.25%) suffered a slight setback. These fluctuations, one suspects, reflect the usual assortment of anxieties concerning data centers, memory costs, and the general capriciousness of fate. It is all rather predictable, really.

ImmunityBio: A Speculative Theorem

Trading volume reached 176 million shares, a figure exceeding the three-month average by an order of magnitude. This, of course, is merely a numerical artifact, a symptom of the underlying irrationality that governs these exchanges. The company, having emerged in 2015, has experienced a decline of 85% since its initial public offering—a reminder that even the most promising trajectories are susceptible to the whims of chance. One is reminded of Zeno’s paradox, where the arrow, though in motion, never truly reaches its destination.

Broadcom’s Grand Illusion

Our subject, Broadcom, presently valued at a respectable, though hardly regal, $1.7 trillion, aspires to join this select company. A feat requiring, shall we say, a rather ambitious performance – a 77% increase in its stock price by the year 2026. One might inquire: is this a realistic expectation, or merely a grand illusion, a puffery designed to entice the gullible investor? Let us, with a touch of skeptical amusement, examine the script.

The Calculating Engine and the Phantom Shares

Meta Platforms, formerly known by a simpler, less ambitious name, has embarked upon a grand experiment. It is accumulating moments, you see – not in albums or diaries, but in the ethereal realm of data. This company, a veritable spider spinning a web of connections, invests heavily in these calculating engines, and the results, thus far, are… intriguing. Revenue and earnings swell, driven by an algorithm that understands, with unsettling accuracy, the human penchant for distraction. The more time one spends gazing at the glowing rectangle, the more attractive the spectacle becomes to those who wish to sell things. It is a peculiar symbiosis, a dance between attention and commerce.

VSS: A Thousand Bucks & a Quiet Hope

But it wasn’t the big boys getting all the attention, not really. It was the little guys. Specifically, the ex-U.S. small-cap stocks, conveniently packaged in funds like the Vanguard FTSE All-World ex-US Small-Cap ETF (VSS +0.08%). Last year, it returned nearly 30%. Thirty percent! Which, in my experience, is enough to make even a seasoned trader briefly consider a career change – maybe alpaca farming. It certainly outperformed the Russell 2000 and the S&P SmallCap 600, which is nice, I suppose. Though I’m not sure those indexes were actively rooting for VSS.

Sprouts & Penn Davis: What’s the Deal?

Apparently, this isn’t a new thing. They’ve been quietly accumulating Sprouts shares. It increased their position, sure, but the value of the whole thing actually went down by $915,227. Nine hundred and fifteen thousand dollars! You buy more shares and the value goes down? It’s like they’re deliberately trying to confuse everyone. I swear, these fund managers just do things to keep themselves entertained. It’s all a game to them. It’s 1.71% of their assets now, which, honestly, feels…arbitrary. Like they pulled that number out of a hat.

Viasat’s Fortunes: A Speculative Rise

By the close of trading, the stock had gained a respectable four and one-tenth percent, a circumstance which suggests a certain eagerness amongst investors, or perhaps merely a lack of more pressing engagements for their capital.

CoreWeave: A Gilded Cage of Silicon

With a capitalization hovering near thirty-nine billion, the company finds itself valued at 3.6 times anticipated sales. A ratio that, to the casual observer, might seem… reasonable. But the market, as any seasoned trader knows, is rarely governed by reason alone. It is a creature of anticipation, of hope, and, increasingly, of a restless anxiety. CoreWeave’s expansion is indeed remarkable, yet the true cost, the hidden liabilities, remain obscured, like a landscape shrouded in mist.